Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T04:39:12.065Z Has data issue: false hasContentIssue false

Chapter 36 - Office care of premenstrual syndrome and premenstrual dysphoric disorder

from Section VI - Nongynecologic conditions

Published online by Cambridge University Press:  05 May 2016

Martin Olsen
Affiliation:
East Tennessee State University
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Office Care of Women , pp. 388 - 393
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Steiner, M, McDougall, M, Brown, E. The premenstrual symptoms screening tool for clinicians. Arch Womens Mental Health. 2003; 6:203209.CrossRefGoogle ScholarPubMed
Endicott, J, Amsterdam, J, Eriksson, E, et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gender-Based Med. 1999; 8:663679.CrossRefGoogle ScholarPubMed
Condone, JT. The premenstrual syndrome: a twin study. Br J Psychiatry. 1993; 162:481486.CrossRefGoogle Scholar
Schmidt, PJ, Nieman, LK, Danaceau, MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. Am J Obstet Gynecol. 1990; 162:99105.Google Scholar
Casson, P, Hahn, PM, Van Vugt, DA. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol. 1991; 162:99105.CrossRefGoogle Scholar
Klatzkin, R, Bunevicius, A, Fomeris, C, Girdler, S. Menstrual mood disorders are associated with blunted sympathetic reactivity to stress. J Psychosom Res. 2014 Jan; 76(1):4655.CrossRefGoogle ScholarPubMed
Case, AM, Reid, RL. Menstrual cycle effects on common medical conditions. Compr Ther. 2001; 27:65.CrossRefGoogle ScholarPubMed
Altman, G, Cain, KC, Motzer, S, et al. Increased symptoms in female IBS patients with dysmennorhea and PMS. Gastroenterol Nurs. 2006; 29:4.CrossRefGoogle Scholar
Roca, CA, Schmidt, PJ, Bloch, M, et al. Implications of endocrine studies of premenstrual syndrome. Psychiatr Ann. 1996; 26:576580.CrossRefGoogle Scholar
Rapkin, AJ, Edelmuth, E, Chang, LC, et al. Whole blood serotonin in premenstrual syndrome. Obstet Gynecol. 1987; 70:533537.Google ScholarPubMed
Taylor, DL, Mathew, RJ, Ho, BT, et al. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology. 1984; 12:1618.CrossRefGoogle ScholarPubMed
Menkes, DB, Coates, DC, Fawcett, JP. Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord. 1994; 32:3744.CrossRefGoogle ScholarPubMed
Albreich, U, Petty, F, Yonkers, K, et al. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry. 1996; 153:718720.Google Scholar
Rapkin, AJ, Shouple, D, Reading, A, et al. Decreased central opioid activity in premenstrual syndrome: leutenizing hormone response to naloxone. J Soc Gynecol Investig. 1996; 3:9396.Google Scholar
Chuong, CJ, Coulam, CB, Bergstralh, EJ, et al. Clinical trial of naltrexone in premenstrual syndrome. Obstet Gynecol. 1988; 72:332336.Google ScholarPubMed
Rapkin, AJ, Morgan, M, Goldman, L, et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol. 1997; 90:709.CrossRefGoogle ScholarPubMed
Guidotti, A, Costa, E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allpregnenolone) availability? Biol Psych. 1998; 44:865873.CrossRefGoogle ScholarPubMed
Wikander, I, Sundblad, C, Andersch, B, et al. Citalopram in premenstrual dysporia: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol. 1998; 18S:390398.CrossRefGoogle Scholar
Freeman, EW, Sonheimer, SJ, Rickels, K. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull. 1997; 33:303309.Google ScholarPubMed
Halbreich, U, Rojansky, N, Palter, S. Elimination of ovulation and menstrual cyclicity (with Danazol) improves dysphoric menstrual syndromes. Fert Steril. 1991; 56:10661069.CrossRefGoogle Scholar
Bancroft, J, Rennie, D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res. 1993; 37:195202.CrossRefGoogle ScholarPubMed
Wyatt, K, Dimmock, P, Jones, P, et al. Efficacy of progesterone and progestogens in management of premenstrual syndrome: a systematic review. BMJ. 2001; 323:134.CrossRefGoogle Scholar
Yonkers, KA, Brown, C, Pearlstein, TB, et al. Efficacy of a new low dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005; 106:492.CrossRefGoogle ScholarPubMed
Thys-Jacobs, S, Starkey, P, Bernstein, D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998; 179:444452.CrossRefGoogle ScholarPubMed
Walker, AF, De Souza, MC, Vicker, MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998; 7:11571165.CrossRefGoogle ScholarPubMed
Stevenson, C, Ernest, E. Complementary/alternative therapies for premenstrual syndrome: asystematic review of randomized controlled trials. Am J Obstet Gynecol. 2001; 185:227.CrossRefGoogle Scholar
Schellenberg, R. Treatment for premenstrual syndrome with angus castus fruit extract: prospective randomized placebo-controlled study. BMJ. 2001; 322:134.CrossRefGoogle Scholar
Blake, F, Salkovskis, P, Gath, D, et al. Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res. 1998; 45:307.CrossRefGoogle ScholarPubMed

Evidence-based references

Douglas, S. Premenstrual syndrome: evidence-based treatment in family practice. Can Fam Physician. 2002; 48:1789.Google ScholarPubMed
Rapkin, AJ. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology. 2003 Aug; 28(Suppl 3):3953.CrossRefGoogle ScholarPubMed
Cunningham, J, Yonkers, K, O’Brien, S, Eriksson, E. Update on research and treatment of premenstrual dysphoric disorder; Harv Rev Psychiatry. 2009; 17(2):120137.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×